Selçuk Ecza Deposu Ticaret ve Sanayi Past Earnings Performance
Past criteria checks 2/6
Selçuk Ecza Deposu Ticaret ve Sanayi's earnings have been declining at an average annual rate of -12.8%, while the Healthcare industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 41.6% per year. Selçuk Ecza Deposu Ticaret ve Sanayi's return on equity is 6%, and it has net margins of 1.5%.
Key information
-12.8%
Earnings growth rate
-12.8%
EPS growth rate
| Healthcare Industry Growth | 58.3% |
| Revenue growth rate | 41.6% |
| Return on equity | 6.0% |
| Net Margin | 1.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Selçuk Ecza Deposu Ticaret ve Sanayi makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 85,759 | 1,252 | 5,358 | 0 |
| 30 Jun 24 | 86,677 | 420 | 5,210 | 0 |
| 31 Mar 24 | 93,549 | -196 | 4,965 | 0 |
| 31 Dec 23 | 97,719 | 223 | 4,657 | 0 |
| 30 Sep 23 | 156,722 | -1,413 | 7,484 | 0 |
| 30 Jun 23 | 137,703 | -44 | 6,444 | 0 |
| 31 Mar 23 | 110,991 | 775 | 5,266 | 0 |
| 31 Dec 22 | 85,197 | 636 | 4,219 | 0 |
| 30 Sep 22 | 38,222 | 1,865 | 1,748 | 0 |
| 30 Jun 22 | 33,249 | 1,294 | 1,472 | 0 |
| 31 Mar 22 | 28,993 | 1,188 | 1,266 | 0 |
| 31 Dec 21 | 26,215 | 923 | 1,095 | 0 |
| 30 Sep 21 | 23,799 | 823 | 994 | 0 |
| 30 Jun 21 | 22,406 | 751 | 955 | 0 |
| 31 Mar 21 | 21,300 | 623 | 916 | 0 |
| 31 Dec 20 | 21,027 | 587 | 892 | 0 |
| 30 Sep 20 | 20,330 | 597 | 862 | 0 |
| 30 Jun 20 | 19,581 | 624 | 824 | 0 |
| 31 Mar 20 | 19,162 | 688 | 800 | 0 |
| 31 Dec 19 | 17,809 | 695 | 772 | 0 |
| 30 Sep 19 | 16,482 | 680 | 737 | 0 |
| 30 Jun 19 | 15,379 | 615 | 711 | 0 |
| 31 Mar 19 | 14,346 | 493 | 680 | 0 |
| 31 Dec 18 | 13,467 | 391 | 646 | 0 |
| 30 Sep 18 | 12,726 | 350 | 616 | 0 |
| 30 Jun 18 | 11,993 | 338 | 581 | 0 |
| 31 Mar 18 | 11,295 | 347 | 548 | 0 |
| 31 Dec 17 | 10,686 | 301 | 521 | 0 |
| 30 Sep 17 | 10,153 | 280 | 494 | 0 |
| 30 Jun 17 | 9,583 | 289 | 471 | 0 |
| 31 Mar 17 | 9,165 | 262 | 459 | 0 |
| 31 Dec 16 | 8,643 | 244 | 430 | 0 |
| 30 Sep 16 | 8,391 | 253 | 414 | 0 |
| 30 Jun 16 | 8,106 | 243 | 397 | 0 |
| 31 Mar 16 | 7,819 | 231 | 375 | 0 |
| 31 Dec 15 | 7,480 | 191 | 359 | 0 |
| 30 Sep 15 | 7,119 | 183 | 340 | 0 |
| 30 Jun 15 | 6,935 | 167 | 329 | 0 |
| 31 Mar 15 | 6,618 | 163 | 311 | 0 |
| 31 Dec 14 | 6,386 | 165 | 303 | 0 |
| 30 Sep 14 | 6,063 | 162 | 284 | 0 |
| 30 Jun 14 | 5,778 | 171 | 279 | 0 |
| 31 Mar 14 | 5,536 | 164 | 270 | 0 |
| 31 Dec 13 | 5,238 | 152 | 269 | 0 |
Quality Earnings: SELEC has high quality earnings.
Growing Profit Margin: SELEC became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SELEC's earnings have declined by 12.8% per year over the past 5 years.
Accelerating Growth: SELEC has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: SELEC has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (8.3%).
Return on Equity
High ROE: SELEC's Return on Equity (6%) is considered low.